Bridgenomics

BRIDGenomics spans diagnostic and life science market segments. We provide intelligence to support genomics based strategies and commercialization of services and products. Our Genomic expertise is built on over 20 years combined global experience in medical device manufacturing, emerging technologies and diagnostics. We bridge industry segments to enable optimization of your market strategy and development pipeline while addressing your needs for a robust regulatory development process. Right Market<>Right Technology<>Right Partner<>On Time With a decade of commercial experience in Next Generation Sequencing (NGS) and advanced sequencing technologies we provide business and technology acumen. We connect IVD companion diagnostic manufacturers, pharma trials, central laboratories and LDT specialty laboratories and help you identify the right path to partnering or outsourcing. • Consulting and Partnering • NGS, Genomics, Personalized medicine • LDT Development Process • Emerging Technology Potential